Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 132 participants.

Also called NCT06949228

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 132 participants (planned count) (from the registry)
Sponsor
ProMedica Health System (from the registry)
Registry
  • NCT NCT06949228
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06949228. Randomized; no masking; primary purpose treatment. Start 2025-07-30 (actual); primary completion 2028-05-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
Acronym
ALLY II TNK
Condition
Acute Disease
Intervention (Drug)
tenecteplase
Lead sponsor
ProMedica Health System (class: other)

Record details

Record id
cardio:ct-nct06949228
Content hash
82bc8ef356e9898fa226e66b7107a37b3b5145ba2ab38d92f40e53106b28523b